-
Analysts Still Searching For A Tailwind To Propel Willis Towers Watson
Tuesday, September 27, 2016 - 3:00pm | 387Read More...UBS sees Wednesday's Willis Towers Watson PLC (NASDAQ: WLTW)'s investor day as a catalyst for the company. Analyst Brian Meredith is looking for a tailwind in respect of revenue growth and margin expansion besides free cash flow. However, analyst is ready to boost the price target from $138 to $145...
-
UBS Loves Berkshire Hathaway Even Without Warren Buffett
Monday, March 28, 2016 - 12:39pm | 390Read More...In a new report, UBS analyst Brian Meredith discusses his bullish outlook for Berkshire Hathaway Inc (NYSE: BRK-A) (NYSE: BRK-B) with or without iconic leader Warren Buffett. Buffett is now 85 years old, but Meredith believes the “Warren Buffett premium” for Berkshire’s stock is...
-
UBS Upgrades Progressive On Completed Deal With ARX
Thursday, April 30, 2015 - 12:31pm | 233Read More...Progressive Corp (NYSE: PGR)'s recently completed $875 million acquisition of a majority stake in homeowners' insurance provider ARX Holding Corp. will boost earnings and send its stock price higher, an analyst said Thursday. UBS's Brian Meredith upgraded Progressive to Buy with a $...
-
XL Group Upgraded To Buy At UBS, Says Benefits Of Catlin Buy 'Not Fully Reflected In Stock'
Tuesday, April 7, 2015 - 10:46am | 250Read More...UBS upgraded XL Group plc (NYSE: XL) Tuesday from Neutral to Buy and raised its price target from $36 to $42. Analysts led by Brian Meredith believed "the financial benefits of the Catlin acquisition, including significant EPS and ROE accretion, will result in multiple expansion over the...
-
UPDATE: UBS Downgrades Travelers Companies, Cites Valuation 'Looks Full'
Thursday, December 11, 2014 - 11:07am | 207Read More...Brian Meredith of UBS downgraded shares of Travelers Companies Inc (NYSE: TRV) to Neutral from Buy on Thursday with a price target raised to $105 from a previous $101. Shares of Travelers have risen 15.2 percent year-to-date, outperforming both the S&P 500 Financials and the company's...
-
XL Issues Better Than Expected Guidance For 2010
Wednesday, February 10, 2010 - 5:06pm | 143Read More...Analyst Brian Meredith of UBS maintains his "buy" rating on XL Capital (NYSE: XL), while raising his estimates for the company. The target price for XL has been raised from 21.00 to 21.50. XL Capital reported its Q4 EPS short of the estimates due to smaller-than-expected loss reserve releases,...
-
AHL EPS Beats Expectations, Revenue Growth Weak
Wednesday, February 10, 2010 - 5:05pm | 129Read More...Analyst Brian Meredith of UBS maintains his "buy" rating on Aspen Insurance (NYSE: AHL), while reducing his estimates for the company. The target price for AHL has been raised from $30 to $31. Aspen Insurance has reported its Q4 EPS significantly ahead of the estimates and the consensus, driven by...
